No association of the CD45 77C>G transversion with inflammatory bowel disease in German patients

International Journal of Immunogenetics

Volumn 35, Issue 4-5, 2008, Pages 335-337

  Thude, H ^a   Rebstock, K ^b   Blume, J ^a   Lutz, B ^a   Barz, D ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b Department of Intensive Medicine   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLELE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE PREDISPOSITION; ENTERITIS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD45; FEMALE; GENE FREQUENCY; GENOTYPE; GERMANY; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; MUTATION; YOUNG ADULT;

EID: 52649168911     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2008.00777.x     Document Type: Article

References (28)

1. Akbar, A., Terry, L., Timms, A., Beverley, P. Janossy, G. (1988) Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. Journal of Immunology, 140, 2171.
2. Ballerini, C., Rosati, E., Salvetti, M., Ristori, G., Cannoni, S., Biagioli, T., Massacesi, L., Sorbi, S. Vergelli, M. (2002) Protein tyrosine phosphatase receptor-type C exon 4 gene mutation distribution in an Italian multiple sclerosis population. Neuroscience Letters, 328, 325.
3. Barcellos, L., Callier, S., Dragone, L., Elder, M., Vittinghoff, E., Bucher, P. et al 2001) PTPRC (CD45) is not associated with the development of multiple sclerosis in US patients. Nature Genetics, 29, 23.
4. Bouma, G. Strober, W. (2003) The immunological and genetic basis of inflammatory bowel disease. Nature Reviews Immunology, 3, 521.
5. Boxall, S., Mccormick, J., Beverley, P., Strobel, S., Filippi, P., Dawes, R. et al 2004) Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis. Pediatric Research, 55, 478.
6. Cocco, E., Murru, M., Melis, C., Schirru, L., Solla, E., Lai, M., Rolesu, M. Marrosu, M.G. (2004) PTPRC (CD45) C77G mutation does not contribute to multiple sclerosis susceptibility in Sardinian patients. Journal of Neurology, 251, 1085.
7. Jacobsen, M., Schweer, D., Ziegler, A., Gaber, R., Schock, S., Schwinzer, R. et al 2000) A point mutation in PTPRC is associated with development of multiple sclerosis. Nature Genetics, 26, 495.
8. Lennard-Jones, J. (1989) Classification of inflammatory bowel disease. Scandinavian Journal of Gastroenterology, Supplement, 170, 2.
9. Lynch, K. Weiss, A. (2001) A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer. Journal of Biological Chemistry, 276, 24341.
10. MacDonald, T. Monteleone, G. (2005) Immunity, inflammation, and allergy in the gut. Science, 307, 1920.
11. Miterski, B., Sindern, E., Haupts, M., Schimrigk, S. Epplen, J. (2002) PTPRC (CD45) is not associated with multiple sclerosis in a large cohort of German patients. BMC Medical Genetics, 16, 3.
12. Miterski, B., Drynda, S., Böschow, G., Klein, W., Oppermann, J., Kekow, J. Epplen, J. (2004) Complex genetic predisposition in adult and juvenile rheumatoid arthritis. BMC Medical Genetics, 5, 2.
13. Penninger, J., Irie-Sasaki, J., Sasaki, T. Oliveira-dos-Santos, A. (2001) CD45: new jobs for an old acquaintance. Nature Immunology, 2, 389.
14. Podolsky, D. (2002) Inflammatory bowel disease. New England Journal of Medicine, 347, 417.
15. + T cell subsets. Journal of Immunology, 148 (12 4054.
16. Rothstein, D., Saito, H., Streuli, M., Schlossmann, S. Morimoto, C. (1992) The alternative splicing of the CD45 tyrosine phosphatase is controlled by negative regulatory trans-acting splicing factors. Journal of Biological Chemistry, 267, 7139.
17. - T cells in healthy individuals. Journal of Experimental Medicine, 171, 1803.
18. Schwinzer, R., Witte, T., Hundrieser, J., Ehlers, S., Momot, T., Hunzelmann, N., Krieg, T., Schmidt, R.E. Wonigeit, K. (2003) Enhanced frequency of a PTPRC (CD45) exon A mutation (77C to G) in systemic sclerosis. Genes and Immunity, 4, 168.
19. Shanahan, F. (2002) Crohn's disease. Lancet, 359, 62.
20. Streuli, M., Hall, L., Saga, Y., Schlossmann, S. Saito, H. (1987) Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens. Journal of Experimental Medicine, 166, 1548.
21. Tchilian, E. Beverley, P. (2006) Altered CD45 expression and disease. Trends in Immunology, 27, 146.
22. Tchilian, E., Wallace, D., Dawes, R., Imami, N., Burton, C., Gotch, F. Beverley, P. (2001) A point mutation in CD45 may be associated with an increased risk of HIV-1 infection. AIDS, 15, 1892.
23. Thomas, M. (1989) The leukocyte common antigen family. Annual Review of Immunology, 7, 339.
24. Thude, H., Hundrieser, J., Wonigeit, K. Schwinzer, R. (1995) A point mutation in the human CD45 gene associated with defective splicing of exon A. European Journal of Immunology, 25, 2101.
25. Thude, H., Rosenhahn, S., Hunger-Dathe, W., Müller, U.A. Barz, D. (2004) A transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77C to G) is not associated with the development of type 1 diabetes mellitus in a German population. European Journal of Immunogenetics, 31, 245.
26. Thude, H., Gerlach, K., Richartz, B., Krack, A., Brenke, B., Pethig, K., Figulla, H. Barz, D. (2005) No association between transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77C>G) and idiopathic dilated cardiomyopathy. Human Immunology, 66 (9 1008.
27. Vogel, A., Strassburg, C. Manns, M. (2003) 77C/G mutation in the tyrosine phosphatase CD45 gene and autoimmune hepatitis: evidence for a genetic link. Genes and Immunity, 4, 79.
28. Wood, J., Bieda, K., Segni, M., Herwig, J., Krause, M., Usadel, K. Badenhoop, K. (2000) CD45 exon 4 point mutation does not confer susceptibility to type 1 diabetes mellitus or Graves' disease. European Journal of Immunogenetics, 29, 73.